Integra LifeSciences (NASDAQ:IART – Get Free Report) and Intuitive Surgical (NASDAQ:ISRG – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.
Valuation and Earnings
This table compares Integra LifeSciences and Intuitive Surgical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Integra LifeSciences | $1.61 billion | 0.54 | -$6.94 million | ($6.46) | -1.74 |
| Intuitive Surgical | $10.06 billion | 17.22 | $2.86 billion | $7.89 | 61.87 |
Insider and Institutional Ownership
84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 3.5% of Integra LifeSciences shares are held by insiders. Comparatively, 0.7% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Integra LifeSciences and Intuitive Surgical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Integra LifeSciences | 3 | 2 | 2 | 0 | 1.86 |
| Intuitive Surgical | 1 | 8 | 15 | 1 | 2.64 |
Integra LifeSciences presently has a consensus target price of $15.00, indicating a potential upside of 33.21%. Intuitive Surgical has a consensus target price of $617.23, indicating a potential upside of 26.44%. Given Integra LifeSciences’ higher probable upside, equities research analysts plainly believe Integra LifeSciences is more favorable than Intuitive Surgical.
Profitability
This table compares Integra LifeSciences and Intuitive Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Integra LifeSciences | -30.15% | 14.06% | 4.70% |
| Intuitive Surgical | 28.38% | 15.06% | 13.34% |
Risk and Volatility
Integra LifeSciences has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500.
Summary
Intuitive Surgical beats Integra LifeSciences on 12 of the 15 factors compared between the two stocks.
About Integra LifeSciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Receive News & Ratings for Integra LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.
